Humacyte Announces Symvess® is Now Under Contract with the Strategic Acquisition Center (SAC) of the U.S. Department of Veterans Affairs
Humacyte announced that its FDA-approved product Symvess is now under contract with the U.S. Department of Veterans Affairs' Strategic Acquisition Center (SAC). The SAC SING contract streamlines the procurement process, making Symvess more easily accessible across 170 VA hospitals without requiring individual hospital approvals.
Key figures
- Va hospitals count
- 170
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.